| Name | IACS-10759 Hydrochloride |
|---|
| Description | IACS-10759 is a potent inhibitor of complex I of oxidative phosphorylation (OXPHOS). |
|---|---|
| Related Catalog | |
| Target |
OXPHOS[1] |
| In Vitro | IACS-10759 inhibits the conversion of NADH to NAD+ in an immunoprecipitated complex I assay at low nM concentrations[1]. |
| In Vivo | IACS-10759 is orally bioavailable with excellent physicochemical properties in preclinical species and achieves significant in vivo efficacy with daily oral dosing of 10-25 mg/kg. There is a >50 day extension of median survival in an orthotopic AML cell line xenograft and robust regression in DLBCL and GBM xenograft models[1]. |
| References |
| Molecular Formula | C25H26ClF3N6O4S |
|---|---|
| Molecular Weight | 599.02 |
| Storage condition | 2-8℃ |